Apr
The Spanish Association of Bioenterprises (ASEBIO) has presented a poster with the portfolio of healthcare products that are being researched by Spanish biotech companies. This Spanish sector pipeline includes 28 companies contributing a total of 119 projects on drugs and diagnosis systems for use on humans and 12 products for animal health care.
Jorge Barrero, ASEBIO General Secretary has highlighted that “this presentation initiative from the Spanish biotechnology sector forms part of a more ambitious programme of activities that will culminate in Granada during the month of September with the BIOSPAIN 2008 International Convention.” The goal pursued by this event, which comprises a science congress, an investor forum and bilateral meetings to forge alliances, is “to give international projection to the capacities of Spanish biotechnology and attract the attention of the world pharmaceutical market regarding the opportunities that exist for collaboration with our country’s biotech companies.”
Among the 19 companies that are developing drugs, the most outstanding is Pharmamar, which in 2007 marketed the first innovative cancer drug developed in Spain. There are other products in the advanced clinical phase (phase III), including the Cellerix cell therapy for treatment of complex fistulas and Palau Pharma’s coronary stent in the cardiovascular field. Other Spanish biotech companies, such as Neuropharma, Advancell, Digna Biotech, Archivel, Thrombotargets or Fina biotech, have more recently entered into clinical phases. In total, ASEBIO has reports of 40 developments in clinical phases (3 in phase III, 24 in phase II and 13 in Phase I) and 50 projects in the preclinical phase.
Furthermore, the ASEBIO survey reports 26 new disease diagnosis and prognosis systems, some are which are soon to come out onto the market. Likewise, in the medical supplies field, the PRGF regeneration technology developed by BTI, a company from the Basque province of álava, also stands out.
Twelve animal health products round up the poster that ASEBIO will distribute internationally to raise awareness concerning Spanish biotechnology capacities and to thus foster its members’ search for allies.
This poster is available here.
About ASEBIO
The Spanish Association of Bioenterprises (ASEBIO) has over 130 members, in the main small enterprises created out of university research and national research centres.
ASEBIO has acted as a meeting and promotion platform for those organisations interested in the development of the national biotechnology scene since 1999. ASEBIO therefore works in close collaboration with regional, national and European governments together with all those social organisations interested in the use of biotechnology for improving the quality of life, the environment and the generation of skilled employment. http://www.asebio.com
About Biospain 2008
Granada will be hosting the fourth edition of the International Biotechnology Convention, BIOSPAIN 2008, from 17th to 19th September 2008, in its Congress and Exhibition Centre. The official inauguration of BIOSPAIN is scheduled to take place on 17th September at 12 o’clock, midday.
BIOSPAIN 2008 is the international presentation platform for the Spanish biotechnology sector and it is intended to satisfy the sector’s commercial and informative demands, providing the necessary tools to take informed decisions and thus be able to address the market’s every increasing requirements.
BIOSPAIN is directed at companies, academics, researchers, financiers and entities related to the Spanish and the international biotech sectors, and it comprises a broad programme spread over three days that aims to link up the main aspects of the biotech environment:
-SCIENCE through the BIOTEC 2008 congress, where renowned scientists and well-known personalities will share a pluri-disciplinary convention in BIOSPAIN. The objective is one of exchanging best practice, making contacts, creating synergies, attracting customers and investors and presenting innovations that pave the way to accessing a sector with excellent growth prospects, under its different working areas, whereby it will foster approaching positions between SCIENCE, TECHNOLOGY and ENTERPRISE.
-POLITICS and SOCIETY, thanks to a full Plenary Session programme, which will offer an opportunity to discover the most up-to-date viewpoints of scientists, the business community and politicians, to generate a debate that will foster support policies for the sector. It will be a meeting point for all professionals in the sector and will act as an observatory for all those social, business and political indicators that help to promote the development of biotechnology as an economic activity and its capacity to lever innovation into the various user sectors.
-BUSINESS DEVELOPMENT through the Partnering event, the international business development encounter, will enable one-to-one meetings between technology suppliers and potential clients, academics and businesspeople, investors and scientists who wish to find out the latest advances in the sector, entering a space with unlimited opportunities during the three days that the activity will last. Prior to visiting BIOSPAIN, all registered participants will be able to organise a personalised agenda of contacts, thanks to an individual work tool which will allow them to learn at all times who will be attending and the interest the event is producing. This will enable meetings to be set up in advance and people to prepare and focus their visit with a greater probability of success and make effective use of the time available.
-FINANCE by attracting capital in the Investors’ Forum. The international investors’ forum will promote the presentation of new projects, facilitating and motivating access to finance, offering continuity to research and business projects. Public and private researchers will present their lines of work before a national and international audience comprising public and private investors, venture capital entities and other related agents. This forum aims to encourage researchers and business seeking finance to undertake their projects, and
-TRADE PROMOTION reflected in a dual Trade Show (companies and institutions). The trade show will host companies and institutions that will share with the visiting public, Scientific community, universities and technology centres, (biotechnology, health sciences, environment, agricultural sciences, nutrition, etc.), university students, businesspeople (from all the areas of the biotech sector), Local, Regional and National Authorities which foster, develop or apply biotechnology, economic agents, finance and venture capital entities, legal firms and information and communications media) the presentation of technical and scientific innovations, in addition to the analysis and observation of the latest projects in the Spanish and international biotech sector.
In its third edition, held in Madrid in September 2007, BIOSPAIN attracted over 1,000 visitors of 20 different nationalities and over 40 exhibitors. In 2008, the Organising Committee expects to double these figures and to do so it has enrolled the support of academics and professionals, public and private institutions and the joint work of the national and international bodies representing all the spheres of biotechnology.
BIOSPAIN 2008 will open exclusively to professionals from this sector on 17th and 18th September, from 09.00 to 18.00 hours and on 19th September from 09.00 to 16.00 hours. The times of the BIOTEC 2008 Scientific Congress can be viewed at http://www.biospain2008.org.
Spanish Association of Bioenterprises